← 返回

以皮下结节和全身性水肿为表现的细胞吞噬性组织细胞性脂膜炎——1 例病例报告

英文原题:Cytophagic Histiocytic Panniculitis Presenting as Subcutaneous Nodules and Generalized Edema - A Case Report.

查看英文原题

Cytophagic Histiocytic Panniculitis Presenting as Subcutaneous Nodules and Generalized Edema - A Case Report.

PubMed 2023/12/12(内容时间) Clin Cosmet Investig Dermatol Q2 · IF 2.5(JCR 2025)

分数与星级只用于站内排序 —— 不代表疗效、安全性或个人适用性。

研究概要

在我们的病例中,患者表现为噬血细胞综合征伴血流动力学不稳定,提示需要强化治疗。

中文摘要

吞噬性组织细胞性脂膜炎(CHP)是一种罕见的结节性脂膜炎,可表现为皮肤红斑、结节、发热、全血细胞减少、肝衰竭、浆细胞增多及肝脾肿大。我们报告一例最初误诊为皮下脂膜炎样T细胞淋巴瘤(SPTCL)的CHP病例,患者最终完全缓解且预后良好。

一名38岁女性因皮下结节、全身水肿及持续发热15天前往皮肤科就诊。

患者具有典型临床表现,包括正电子发射断层显像/计算机断层扫描(PET/CT)最大标准化摄取值(SUVmax)较低、T细胞分化良性、TCR基因重排阴性、全血细胞减少、凝血异常、甘油三酯升高、NK细胞计数下降、肝功能受损,以及骨髓活检涂片中观察到噬血细胞;据此诊断为CHP合并噬血细胞综合征。

本病例患者出现伴血流动力学不稳定的噬血细胞综合征,提示需要强化治疗。SPTCL的诊断需要细致的鉴别诊断流程,并应谨慎使用强效化疗方案。必须进行长期随访以确定远期结局。

展开英文摘要原文

Cytophagic histiocytic panniculitis (CHP) is a rare form of nodular panniculitis characterized by clinical manifestations such as skin erythema, nodules, fever, pancytopenia, liver failure, plasmacytosis, and hepatosplenomegaly. We report a case of CHP that was initially misdiagnosed as subcutaneous panniculitis-like T-cell lymphoma (SPTCL) but achieved complete remission with a favorable prognosis.

A 38-year-old female presented to the dermatology department with a 15-day history of subcutaneous nodules, generalized edema, and continuous fever.

The patient was diagnosed as CHP combined with hemophagocytic syndrome by typical clinical manifestations, low value of SUVmax in positron emission tomography/computed tomography (PET/CT), benign differentiated T cells, negative TCR gene rearrangement, pancytopenia, abnormal coagulation, hypertriglyceridemia, decreased NK cell count, impaired liver function, and the presence of hemophagocytic cells observed in bone biopsy smears.

In our case, the patient presented with hemophagocytic syndrome with hemodynamic instability, indicating an intensive treatment is needed. The diagnosis of SPTCL necessitates a meticulous process of differential diagnosis, along with the cautious administration of an aggressive chemotherapy regimen. Extended follow-up is imperative to ascertain the long-term outcomes.

论文信息

作者
Yang J、Chen L、Shi R、Zhao X、Pan M、Zheng J
单位
Department of Dermatology, School of Medicine, Ruijin Hospital, Shanghai Jiao Tong University, Shanghai, People's Republic of China.China
文献类型
病例报告
期刊
Clinical, cosmetic and investigational dermatology2023
原文标识
PubMed 38107669 · DOI 10.2147/CCID.S437208